MedTrace Logo

A Clinical Study of Systane® Lid Wipes in Brazil

NCT02380261 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2016-11-18

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to verify the skin and ocular tolerance of the product Systane® Lid Wipes.

Conditions

  • Ocular Tolerance
  • Skin Tolerance

Interventions

OTHER

Systane® Lid Wipes

Commercially-marketed, individually-packaged, pre-moistened eyelid wipe for daily cleaning

Sponsors & Collaborators

  • NOVARTIS BIOCIENCIAS S/A

    collaborator UNKNOWN

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Medical Director · Alcon Brazil

Study Design

Allocation
NA
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2015-10-31
Completion
2015-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02380261 on ClinicalTrials.gov